This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.80% per year. These returns cover a period from January 1, 1988 through August 3, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Quest Diagnostics (DGX) Q3 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Quest Diagnostics (DGX) delivered earnings and revenue surprises of 1.37% and 1.66%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?
What's in Store for Option Care Health (OPCH) in Q3 Earnings?
by Zacks Equity Research
Option Care Health's (OPCH) Q3 results are likely to be driven by sustained strong utilization.
OPCH or CHE: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
OPCH vs. CHE: Which Stock Is the Better Value Option?
Zacks.com featured highlights Arcos Dorados Holdings, Karat Packaging, The Andersons and Option Care Health
by Zacks Equity Research
Arcos Dorados Holdings, Karat Packaging, The Andersons and Option Care Health have been highlighted in this Screen of The Week article.
2 Top Ranked Stocks with Sky High Earnings Growth Forecasts
by Ethan Feller
Earnings growth is a leading indicator of a company's financial health and its potential for future stock price appreciation
Pick These 4 Solid Net Profit Margin Stocks for Solid Returns
by Anirudha Bhagat
Here we present four top-ranked stocks, ARCO, KRT, ANDE and OPCH, with solid net profit margins that can contribute toward making a strong portfolio.
Top Medical Stocks to Buy Amid Market Volatility
by Shaun Pruitt
While there is no guarantee that medical stocks will offer a hedge against market volatility, healthcare is essential even during economic uncertainty.
Best Growth Stocks to Buy for September 27th
by Zacks Equity Research
AMWD, OPCH and JOB made it to the Zacks Rank #1 (Strong Buy) growth stocks list on September 27, 2023.
Best Growth Stocks to Buy for September 19th
by Zacks Equity Research
JOB, OPCH and SPLK made it to the Zacks Rank #1 (Strong Buy) growth stocks list on September 19, 2023.
Recent Price Trend in Option Care (OPCH) is Your Friend, Here's Why
by Zacks Equity Research
Option Care (OPCH) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.